(Q39598551)

13 September 2017

Validation of a multiplex immunoassay for serum angiogenic factors as biomarkers for aggressive prostate cancer (English)

1 reference

13 September 2017

0 references

1 reference

Danni Li

1

1 reference

13 September 2017

Hanching Chiu

series ordinal

2

1 reference

13 September 2017

Vinita Gupta

series ordinal

3

1 reference

13 September 2017

Daniel W Chan

series ordinal

4

1 reference

13 September 2017

18 June 2012

1 reference

13 September 2017

1 reference

13 September 2017

413

1 reference

13 September 2017

19-20

1 reference

13 September 2017

1506-1511

1 reference

Prognostic significance of angiogenesis and angiogenic growth factors in nonsmall cell lung cancer

13 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4086634

The road from discovery to clinical diagnostics: lessons learned from the first FDA-cleared in vitro diagnostic multivariate index assay of proteomic biomarkers

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4086634

Inhibition of angiopoietin-2 in LuCaP 23.1 prostate cancer tumors decreases tumor growth and viability

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4086634

Antibody-based protein multiplex platforms: technical and operational challenges

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4086634

The changing face of low-risk prostate cancer: trends in clinical presentation and primary management

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4086634

Serum levels of IL-6 and TNF-alpha correlate with clinicopathological features and patient survival in patients with prostate cancer

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4086634

Role of osteopontin in tumour progression

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4086634

Angiogenesis in prostate cancer: its role in disease progression and possible therapeutic approaches

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4086634

Her-2/neu expression in prostate cancer: high level of expression associated with exposure to hormone therapy and androgen independent disease

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4086634

Relative expression of type IV collagenase, E-cadherin, and vascular endothelial growth factor/vascular permeability factor in prostatectomy specimens distinguishes organ-confined from pathologically advanced prostate cancers

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4086634

Association between immunohistochemical expression of vascular endothelial growth factor (VEGF), VEGF-expressing neuroendocrine-differentiated tumor cells, and outcome in prostate cancer patients subjected to watchful waiting

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4086634

Elevated levels of circulating interleukin-6 and transforming growth factor-beta1 in patients with metastatic prostatic carcinoma

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4086634

Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4086634

Hepatocyte growth factor and its receptor (c-MET) in prostatic carcinoma

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4086634

Endothelial cell proliferation in prostatic carcinoma and prostatic hyperplasia: correlation with Gleason's score, microvessel density, and epithelial cell proliferation.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4086634

Constitutive production of platelet-derived growth factor-like proteins by human prostate carcinoma cell lines.

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4086634

Basic fibroblast growth factor in human prostate cancer cells

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4086634

The addition of interleukin-6 soluble receptor and transforming growth factor beta1 improves a preoperative nomogram for predicting biochemical progression in patients with clinically localized prostate cancer

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4086634

Differential expression of specific FGF ligand and receptor isoforms during angiogenesis associated with prostate cancer progression

21 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4086634

Her-2-neu expression and progression toward androgen independence in human prostate cancer.

21 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4086634

Tumor angiogenesis is associated with progression after radical prostatectomy in pT2/pT3 prostate cancer

21 August 2018

1 reference

12 December 2020

Gleason score 7 prostate cancer on needle biopsy: relation of primary pattern 3 or 4 to pathological stage and progression after radical prostatectomy

1 reference

12 December 2020

Vascular endothelial growth factor and its correlation with angiogenesis and p53 expression in prostate cancer

1 reference

12 December 2020

Increased serum concentration of angiogenic factors in malignant melanoma patients correlates with tumor progression and survival

1 reference

12 December 2020

Scatter factor-hepatocyte growth factor elevation in the serum of patients with prostate cancer

1 reference

12 December 2020

Angiogenesis and prostate cancer: identification of a molecular progression switch

1 reference

12 December 2020

HER-2/neu (p185neu) protein expression in the natural or treated history of prostate cancer

1 reference

12 December 2020

Thrombospondin-1, vascular endothelial growth factor and fibroblast growth factor-2 are key functional regulators of angiogenesis in the prostate

1 reference

12 December 2020

HER-2 profiling and targeting in prostate carcinoma

1 reference

12 December 2020

Soluble epidermal growth factor receptor (sEGFR/sErbB1) as a potential risk, screening, and diagnostic serum biomarker of epithelial ovarian cancer

1 reference

12 December 2020

Quantitative expression of protein markers of plasminogen activation system in prognosis of colorectal cancer

1 reference

12 December 2020

Changes in serum soluble VEGFR-1 and Tie-2 receptors in colorectal cancer patients following surgical resections

1 reference

12 December 2020

Platelet-derived growth factor induces proliferation of hyperplastic human prostatic stromal cells

1 reference

12 December 2020

Platelet-derived growth factor A and B chains and the alpha and beta receptors in prostatic intraepithelial neoplasia

1 reference

12 December 2020

Pretreatment serum level of HER2/nue as a prognostic factor in metastatic prostate cancer patients about to undergo endocrine therapy

1 reference

12 December 2020

Co-expression of angiogenic markers and associations with prognosis in advanced epithelial ovarian cancer: a Gynecologic Oncology Group study

1 reference

12 December 2020

Changes in Gleason score grading and their effect in predicting outcome after radical prostatectomy

1 reference

12 December 2020

10.1016/J.CCA.2012.06.017

Identifiers

DOI

1 reference

release_gjtdqpuqr5gdfmqug3sbkpr3sq

13 September 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/gjtdqpuqr5gdfmqug3sbkpr3sq

24 November 2022

mapped directly with Wikidata item

1 reference

13 September 2017

PubMed publication ID

22722017

1 reference